Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research
Pillser
Search
Sign UpLog In
Myth-buster

Probiotic L. helveticus Rosell-52 failed to improve red blood cell measures in a 116-person trial of adults with depression — the same study hinted at a stabilizing effect on some hemoglobin markers, but the primary analysis found no significant benefit over placebo.

This null result challenges any expectation that this specific probiotic strain meaningfully boosts red blood cell health in people with depression, but since it's one of the first studies on this pairing, the picture is far from settled — more research is needed before drawing firm conclusions.

In a randomized controlled trial of 116 adults with depressive disorder, 60 days of Lactobacillus helveticus Rosell-52 did not significantly change red blood cell parameters compared to placebo. While the researchers noted a possible stabilizing effect on some hemoglobin-related measures, the overall evidence for a meaningful benefit was lacking, and the study's secondary nature means these findings should be treated as preliminary.

Where this fits in the evidence

This is among the first studies we've indexed on Lactobacillus helveticus Rosell-52 for No Significant Changes in Blood Parameters — treat it as an early signal until more research accumulates.

The study

Limited Changes in Red Blood Cell Parameters After Probiotic Supplementation in Depressive Individuals: Insights from a Secondary Analysis of the PRO-DEMET Randomized Controlled Trial.

  • Randomized Controlled Trial (RCT)
  • n = 116
  • 2025-01-05
  • Journal of clinical medicine
More on Lactobacillus helveticus Rosell-52More on No Significant Changes in Blood Parameters

This is a plain-language summary of a research finding, not medical advice. Pillser surfaces research signals to help you decide what's worth investigating — always consult a qualified professional before changing what you take.

Back to top